Literature DB >> 3592805

Is an aggressive surgical approach to the patient with gastric lymphoma warranted?

C B Rosen, J A van Heerden, J K Martin, L E Wold, D M Ilstrup.   

Abstract

At the Mayo Clinic, from 1970 through 1979, 84 patients (52 males and 32 females) had abdominal exploration for primary gastric lymphoma. All patients were observed a minimum of 5 years or until death. The histologic findings for all 84 patients were reviewed. Forty-four patients had "curative resection," and 40 patients had either biopsy alone or a palliative procedure. The probability of surviving 5 years was 75% for patients after potentially curative resection and 32% for patients after biopsy and palliation (p less than 0.001). The operative mortality rate was 5% overall and 2% after potentially curative resection. Increased tumor size (p less than 0.02), increased tumor penetration (p less than 0.01), and lymph node involvement (p less than 0.02) decreased the probability of survival, whereas histologic classification did not affect survival. Radiation therapy after surgery did not significantly affect the survival rate for the entire group or the survival rate for patients who had potentially curative resection. Resectability was associated with increased patient survival--independent of other prognostic factors--when our experience was analyzed by the Cox proportional-hazards model (p less than 0.005). It was concluded that an aggressive surgical attitude in the treatment of primary gastric lymphoma is warranted. The role of radiotherapy remains in question.

Entities:  

Mesh:

Year:  1987        PMID: 3592805      PMCID: PMC1493050          DOI: 10.1097/00000658-198706000-00004

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  Malignant lymphoma of the stomach.

Authors:  T N Moore; H J Scruggs; R D Marks; K M Wallace
Journal:  J S C Med Assoc       Date:  1977-07

2.  Prognosis in gastric lymphoma.

Authors:  S O Hoerr; L J McCormack; N R Hertzer
Journal:  Arch Surg       Date:  1973-08

3.  Sarcomatous lesions of the stomach.

Authors:  J N Burgess; M B Dockerty; W H ReMine
Journal:  Ann Surg       Date:  1971-05       Impact factor: 12.969

4.  Gastric lymphosarcoma. Clinicopathologic analysis of 71 cases and its relation to disseminated lymphosarcoma.

Authors:  J I Joseph; R Lattes
Journal:  Am J Clin Pathol       Date:  1966-06       Impact factor: 2.493

5.  Factors in the prognosis of gastric lymphoma.

Authors:  F E Lim; A S Hartman; E G Tan; B Cady; W A Meissner
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

6.  Primary lymphomas and sarcomas of the stomach.

Authors:  A Y Bedikian; N Khankhanian; L K Heilbrun; M Valdivieso
Journal:  South Med J       Date:  1980-01       Impact factor: 0.954

7.  Primary gastric lymphoma. An analysis with emphasis on prognostic factors and radiation therapy.

Authors:  D S Shimm; D E Dosoretz; T Anderson; R M Linggood; N L Harris; C C Wang
Journal:  Cancer       Date:  1983-12-01       Impact factor: 6.860

8.  Primary gastrointestinal lymphoma: a 30-year review.

Authors:  D N Weingrad; J J Decosse; P Sherlock; D Straus; P H Lieberman; D A Filippa
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

9.  The role of surgery in the management of gastric lymphoma.

Authors:  I D Fleming; S Mitchell; R A Dilawari
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

10.  Management of primary gastric lymphoma.

Authors:  M H Shiu; M Karas; L Nisce; B J Lee; D A Filippa; P H Lieberman
Journal:  Ann Surg       Date:  1982-02       Impact factor: 12.969

View more
  12 in total

1.  Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients.

Authors:  Alexander Darom; Ilias P Gomatos; Emmanuel Leandros; Emmu Chatzigianni; Dimitris Panousopoulos; Manousos M Konstadoulakis; George Androulakis
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

Review 2.  Current status of gastric MALT lymphoma.

Authors:  T Wündisch; M Stolte
Journal:  Curr Gastroenterol Rep       Date:  2006-10

Review 3.  Update on gastric lymphoma.

Authors:  C R Thomas
Journal:  J Natl Med Assoc       Date:  1991-08       Impact factor: 1.798

4.  Primary non-Hodgkin's lymphoma of the stomach: three radical modalities of treatment in 75 patients.

Authors:  I B Shchepotin; S R Evans; M Shabahang; V Chorny; R R Buras; V Korobko; A Zadorozhny; R J Nauta
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

5.  Long-term follow-up after curative surgery for early gastric lymphoma.

Authors:  D L Bartlett; M S Karpeh; D A Filippa; M F Brennan
Journal:  Ann Surg       Date:  1996-01       Impact factor: 12.969

6.  The role of radical gastrectomy with systematic lymphadenectomy for the diagnosis and treatment of primary gastric lymphoma.

Authors:  Y Kodera; Y Yamamura; S Nakamura; Y Shimizu; A Torii; T Hirai; K Yasui; T Morimoto; T Kato; T Kito
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

7.  Effects of DNA ploidy patterns on the survival of patients with primary gastrointestinal lymphoma.

Authors:  A Okuda; H Suzuki
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

8.  Gastric B-cell mucosa associated lymphoid tissue lymphoma: a clinicopathological study in 56 patients.

Authors:  J M Castrillo; C Montalban; G Obeso; M A Piris; M C Rivas
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

Review 9.  The diminishing role of surgery in the treatment of gastric lymphoma.

Authors:  Sam S Yoon; Daniel G Coit; Carol S Portlock; Martin S Karpeh
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

10.  The role of surgery in primary gastric lymphoma: results of a controlled clinical trial.

Authors:  Agustin Avilés; M Jesús Nambo; Natividad Neri; Judith Huerta-Guzmán; Ivonne Cuadra; Isabel Alvarado; Claudia Castañeda; Raúl Fernández; Martha González
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.